Skip to content
healthcare.dev

LISINOPRIL AND HYDROCHLOROTHIAZIDE

NDC 60760-063, LISINOPRIL AND HYDROCHLOROTHIAZIDE, tablet, from St Marys Medical Park Pharmacy.

Product NDC
60760-063
Status
Listed
Labeler
St Marys Medical Park Pharmacy
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077912
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60760-063 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDROCHLOROTHIAZIDE12.5 mg/1
  • LISINOPRIL10 mg/1

Pharmacologic classes

Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package
60760-063-906076000639090 TABLET in 1 BOTTLE, PLASTIC (60760-063-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e7b68ea6-4fc8-441a-9640-1ccd3a482d8e

Use it

Look up 60760-063 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60760-063 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60760-063. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.